Pfizer Sues IVAX To Protect Market For Detrol

Law360, New York (January 18, 2007, 12:00 AM EST) -- Pfizer Inc. has filed a patent infringement suit against a subsidiary of Israeli generics maker Teva Pharmaceuticals Industries Ltd. in an attempt to protect the market for the world’s leading prescription bladder control drug Detrol.

The lawsuit, brought by Pfizer Inc. and subsidiaries Pharmacia & Upjohn Co. and Pfizer Health AB, was filed in New Jersey against Miami, Fla.-based IVAX Pharmaceuticals Inc. on Jan. 11. IVAX was acquired by Teva in January 2006.

At issue is U.S. Patent No. 5,382,600—which Pfizer Health AB holds the rights...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.